Manchester United have finalized an agreement to bring Brighton & Hove Albion's midfield talent Carlos Baleba to Old Trafford for a total package worth £70 million. The structure of the deal includes a guaranteed £65 million fee, with an additional £5 million in performance‑related add‑ons, and Brighton have secured a sell‑on clause to benefit from any future transfer. Baleba is set to commit to a five‑year contract with the Red Devils and will undergo his medical examination within the next 24 hours.
The interest in Baleba has been a long‑running storyline for United. Sky Sports News first reported United’s fascination with the 22‑year‑old during the previous autumn and later confirmed that the club had made an inquiry in the January window.
Despite missing out then, Baleba remained a top priority this summer, becoming the third midfield signing after Andrey Santos and Youri Tielemans. According to a source cited by Sky Sports, United’s initial bid last summer was even higher than the £100 million fee Chelsea paid for Moisés Caicedo in 2023, plus £15 million in potential add‑ons. Although Baleba’s form dipped during the 2022‑23 season, United’s hierarchy appears satisfied with the current £70 million package, reflecting a sustained belief in his long‑term potential. Baleba is currently rehabilitating from an ankle‑ligament injury sustained in pre‑season.
Medical staff expect him to be fit by mid‑September, just in time for United’s early fixtures against Manchester City on September 13 and Fulham on September 20. The subsequent three‑week international break should give him ample opportunity to settle into the squad and adapt to life at the Theatre of Dreams. Analysis from Sky Sports’ William Bitibiri provides context on Baleba’s journey. A year ago, the Brighton midfielder seemed destined for a move to a European heavyweight after a breakout season that saw him hailed as one of the Premier League’s most promising young midfielders.
United were among the clubs that identified him as a potential game‑changer, but Brighton’s asking price—reported at over £100 million—proved prohibitive, and the transfer collapsed, leaving Baleba at the Amex Stadium. The following season, Baleba’s performances waned. His statistical output declined, and he often appeared a shadow of the dynamic playmaker who had captured headlines.
This regression has introduced an element of risk for United, who are now betting on the player he could become rather than the one he has been over the past twelve months. From a tactical standpoint, Baleba fits a specific need in United’s midfield. The club seeks greater authority in the central areas and a player capable of winning the ball back deep in their own half.
Baleba offers a blend of athleticism, aggression, and ball‑carrying ability that could inject the dynamism and defensive steel currently lacking. While Santos and Tielemans have provided quality, Baleba brings a more specialized defensive power combined with the physicality to drive the team forward.
His youth is another compelling factor. At just 22, Baleba still possesses a significant development ceiling. He has expressed admiration for midfield legends such as Paul Pogba, Yaya Toure, and Andrés Iniesta, and even cites Neymar and Ronaldinho as favorite players to watch, indicating a desire to blend physical prowess with creative flair.
This mix of influences suggests a player eager to evolve beyond raw athleticism into a more rounded, expressive midfielder. The gamble involved in signing Baleba is clear: United are investing in potential upside. If the club can nurture his talents, he could mature into one of the world’s elite midfielders, offering both defensive solidity and forward thrust.
The deal also includes a sell‑on clause, which protects Brighton’s interests and reflects the belief that Baleba’s market value could rise sharply if his development proceeds as hoped. In summary, Manchester United’s £70 million acquisition of Carlos Baleba represents a calculated risk aimed at securing a young, versatile midfielder who can address immediate defensive needs while possessing the ceiling to become a cornerstone of the team for years to come. The upcoming medical, his expected return to fitness, and the early season fixtures will be the first tests of whether this investment will pay dividends on the pitch.